Tapewire

Nasdaq · USD

PTCT

PTC THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
3803
SEC CIK
0001070081
Parsed reports
477

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025039
Dec 2025021
Jan 2026042
Feb 2026014
Mar 202606
Apr 202607
May 2026010
Jun 2026018
Jul 2026020
Aug 2026012
Sep 202608
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionCommon Stock 7,720 $33.02 $254,914.40
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 7

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 600 $53.04 $31,824.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 6

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,389

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionCommon Stock 600 $33.02 $19,812.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 5

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 2,060 $0.00 Strike: $51.00 $0.00
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · derivative · entry 12

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 0

Underlying: Common Stock · 2,060 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on February 21, 2023.

F9 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 66,956 $0.00 Strike: $51.00 $0.00
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · derivative · entry 11

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 66,956 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.

F9 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 2,594 $0.00 Strike: $51.00 $0.00
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · derivative · entry 10

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,956

Underlying: Common Stock · 2,594 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.

F9 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 277 $52.76 $14,614.52
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 9

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 4,576

F6 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on February 21, 2023.

F8 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.65 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 1,783 $51.85 $92,448.55
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 8

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 4,853

F6 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on February 21, 2023.

F7 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.50 to $52.45 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
Exercise / conversionCommon Stock 2,060 $51.00 $105,060.00
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 7

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse

Disclosed balance after: 6,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on February 21, 2023.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 8,611 $52.72 $453,971.92
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 6

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,202

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.505 to $52.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 58,345 $51.97 $3,032,189.65
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 5

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,813

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.50 to $52.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
Exercise / conversionCommon Stock 66,956 $51.00 $3,414,756.00
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 4

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 153,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 266 $52.73 $14,026.18
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 3

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,202

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.58 to $52.84 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
SaleCommon Stock 2,328 $51.85 $120,706.80
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 2

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,468

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.

F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.50 to $52.47 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
Exercise / conversionCommon Stock 2,594 $51.00 $132,294.00
Disclosure

SEC source: 0001415889-24-028289 · form4-12042024_051208.xml · nonDerivative · entry 1

Almstead Neil Gregory · CIK 0001578850 · CHIEF TECHNICAL OPS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,796

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 21, 2023.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $30.86 $0.00
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · derivative · entry 9

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2026-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $51.00 $0.00
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · derivative · entry 8

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC SaleCommon Stock 3,667 $52.39 $192,114.13
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · nonDerivative · entry 7

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,500

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on May 22, 2024

F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.02 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC SaleCommon Stock 2,634 $51.43 $135,466.62
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · nonDerivative · entry 6

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,167

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on May 22, 2024

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.00 to $51.86 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC SaleCommon Stock 5,699 $50.52 $287,913.48
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · nonDerivative · entry 5

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,801

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on May 22, 2024

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to 50.995 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC Exercise / conversionCommon Stock 12,000 $30.86 $370,320.00
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · nonDerivative · entry 4

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on May 22, 2024

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC SaleCommon Stock 3,187 $52.42 $167,062.54
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · nonDerivative · entry 3

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,500

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on May 22, 2024

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.10 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC SaleCommon Stock 8,813 $51.44 $453,340.72
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · nonDerivative · entry 2

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,687

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on May 22, 2024

F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.10 to $52.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC Exercise / conversionCommon Stock 12,000 $51.00 $612,000.00
Disclosure

SEC source: 0001415889-24-028287 · form4-12042024_051205.xml · nonDerivative · entry 1

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on May 22, 2024

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 14,695 $0.00 Strike: $51.00 $0.00
Disclosure

SEC source: 0001415889-24-028286 · form4-12042024_051203.xml · derivative · entry 8

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,695 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.

F6 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 3,105 $0.00 Strike: $51.00 $0.00
Disclosure

SEC source: 0001415889-24-028286 · form4-12042024_051203.xml · derivative · entry 7

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,695

Underlying: Common Stock · 3,105 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.

F6 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 4,776 $52.45 $250,501.20
Disclosure

SEC source: 0001415889-24-028286 · form4-12042024_051203.xml · nonDerivative · entry 6

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,428

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.15 to $52.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 9,919 $51.53 $511,126.07
Disclosure

SEC source: 0001415889-24-028286 · form4-12042024_051203.xml · nonDerivative · entry 5

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,204

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.15 to $52.11 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon Stock 14,695 $51.00 $749,445.00
Disclosure

SEC source: 0001415889-24-028286 · form4-12042024_051203.xml · nonDerivative · entry 4

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,123

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 608 $52.24 $31,761.92
Disclosure

SEC source: 0001415889-24-028286 · form4-12042024_051203.xml · nonDerivative · entry 3

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,428

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.16 to $52.41 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
SaleCommon Stock 2,497 $51.34 $128,195.98
Disclosure

SEC source: 0001415889-24-028286 · form4-12042024_051203.xml · nonDerivative · entry 2

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,036

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.

F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.15 to $52.06 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
Exercise / conversionCommon Stock 3,105 $51.00 $158,355.00
Disclosure

SEC source: 0001415889-24-028286 · form4-12042024_051203.xml · nonDerivative · entry 1

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,533

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 27, 2024.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionStock Option (Right to Buy) · Derivative 83,640 $0.00 Strike: $51.00 $0.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · derivative · entry 14

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 83,640 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,960 $0.00 Strike: $51.00 $0.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · derivative · entry 13

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,640

Underlying: Common Stock · 1,960 shares

Expires 2025-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F8 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 83,640 $52.26 $4,371,026.40
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 4

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,389

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.00 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionCommon Stock 83,640 $51.00 $4,265,640.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 3

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 176,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
SaleCommon Stock 1,960 $52.17 $102,253.20
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 2

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,389

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.00 to $52.83 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:20 UTC
Boulding Mark ElliottEXEC. VP AND CLO
Exercise / conversionCommon Stock 1,960 $51.00 $99,960.00
Disclosure

SEC source: 0001415889-24-028285 · form4-12042024_051201.xml · nonDerivative · entry 1

Boulding Mark Elliott · CIK 0001578852 · EXEC. VP AND CLO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,349

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.

Read SEC document
July 16, 2024 Filed Jul 18, 2024 21:20 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
SaleCommon Stock 2,269 $34.02 $77,200.46
Disclosure

SEC source: 0001415889-24-019773 · form4-07182024_050701.xml · nonDerivative · entry 1

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,531

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a July 13, 2023 grant of 26,000 RSUs.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $26.42 $0.00
Disclosure

SEC source: 0001415889-24-014552 · form4-05242024_050501.xml · derivative · entry 3

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2024-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Currently exercisable.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:20 UTC SaleCommon Stock 20,000 $38.24 $764,800.00
Disclosure

SEC source: 0001415889-24-014552 · form4-05242024_050501.xml · nonDerivative · entry 2

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,500

F1 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $38.20 to $38.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:20 UTC Exercise / conversionCommon Stock 20,000 $26.42 $528,400.00
Disclosure

SEC source: 0001415889-24-014552 · form4-05242024_050501.xml · nonDerivative · entry 1

ZELDIS JEROME B · CIK 0001433982 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 08, 2024 Filed May 10, 2024 21:20 UTC GiftCommon Stock 1,650 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-012891 · form4-05102024_050502.xml · nonDerivative · entry 1

SOUTHWELL DAVID P · CIK 0001251553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,850

F1 · kind: Represents the transfer of shares by the Reporting Person to The David P. Southwell Irrevocable Trust of 2024 (the "Trust") for no consideration. The Trust has an independent trustee with investment control over the transferred shares, and the Reporting Person and members of his family are the beneficiaries of the Trust.

Read SEC document
May 07, 2024 Filed May 8, 2024 21:20 UTC
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
SaleCommon Stock 175 $32.82 $5,743.50
Disclosure

SEC source: 0001415889-24-012633 · form4-05082024_050501.xml · nonDerivative · entry 1

Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,813

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 713 RSUs from a May 11, 2020 grant of 2,850 RSUs.

Read SEC document
April 19, 2024 Filed Apr 22, 2024 21:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 3,361 $24.89 $83,668.73
Disclosure

SEC source: 0001415889-24-011329 · form4-04222024_050401.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 225,807

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from an April 18, 2023 grant of 26,000 RSUs.

Read SEC document
April 17, 2024 Filed Apr 19, 2024 21:20 UTC
Pauwels EricDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 787 $25.14 $19,781.25
Disclosure

SEC source: 0001415889-24-011248 · form4-04192024_050404.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,694

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from an April 16, 2020 grant of 10,000 RSUs.

Read SEC document
April 17, 2024 Filed Apr 19, 2024 21:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 1,307 $25.14 $32,851.45
Disclosure

SEC source: 0001415889-24-011247 · form4-04192024_050401.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 229,168

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from an April 16, 2020 grant of 10,000 RSUs.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 21:16 UTC
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
SaleCommon Stock 526 $28.37 $14,922.62
Disclosure

SEC source: 0001415889-24-010313 · form4-04042024_090422.xml · nonDerivative · entry 1

Golden Lee Scott · CIK 0001686217 · EVP & CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,988

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 2,100 RSUs from a April 24, 2023 grant of 8,400 RSUs.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:00 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
GrantStock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $25.69 $0.00
Disclosure

SEC source: 0001415889-24-004163 · form4-02162024_050204.xml · derivative · entry 3

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2034-02-14

F3 · derivative.exercise_date: This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:00 UTC
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
GrantCommon Stock 2,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-004163 · form4-02162024_050204.xml · nonDerivative · entry 2

Utter Christine Marie · CIK 0001707685 · SVP, CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,428

F2 · shares: Restricted stock units granted on February 15, 2024 that vest in two equal installments over two years, commencing on February 15, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.